The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Leading pharmaceutical and IT companies have said they will quit Ireland if a proposed ban on so-called forever chemicals is ...

Investors often hold blue-chip stocks at the core of their portfolios. That makes sense. After all, blue-chip companies are ...

The first stunt in this vein was held in New York in 2002, the brainchild of local comedian Charlie Todd. His idea was this: Wouldn’t it be funny if someone walked onto a subway train in the middle of ...

In 1996, a pharmaceutical giant, Pfizer, administered a drug known as ... in to shoulder the burden of her school fees, feeding, clothing, and transportation. However, the emotional toll of ...

Arbutus Biopharma Corporation ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic ...

We think Pfizer stock is worth $42 per share ... Footwear and Accessories Footwear and apparel giant Nike rejoins our list of the best companies to buy now and rounds out the group.

Pfizer is set to raise £2.5bn by selling a 7.7% stake in Haleon, the UK consumer healthcare company, in a block trade on ...

Kansas City Chiefs tight end Travis Kelce and pop superstar Taylor Swift are a power couple, as both have risen to the top of their respective fields. Swift has amassed a massive following and ...

Attorney General Ken Paxton, shown at a 2023 news conference, had accused Pfizer of making misleading claims about the effectiveness of its COVID-19 vaccine. Paxton wanted the pharmaceutical giant ...

Pfizer's stock has underperformed, but management's focus on R&D and cost efficiencies should boost margins and free cash flow, supporting a Buy rating. Despite political headwinds, PFE's ...